<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35753345</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>298</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Casein kinase 1&#x3b4;/&#x3b5; phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration.</ArticleTitle><Pagination><StartPage>102191</StartPage><MedlinePgn>102191</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102191</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2022.102191</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(22)00633-0</ELocationID><Abstract><AbstractText>Aberrant cytoplasmic accumulation of an RNA-binding protein, fused in sarcoma (FUS), characterizes the neuropathology of subtypes of ALS and frontotemporal lobar degeneration, although the effects of post-translational modifications of FUS, especially phosphorylation, on its neurotoxicity have not been fully characterized. Here, we show that casein kinase 1&#x3b4; (CK1&#x3b4;) phosphorylates FUS at 10 serine/threonine residues in&#xa0;vitro using mass spectrometric analyses. We also show that phosphorylation by CK1&#x3b4; or CK1&#x3b5; significantly increased the solubility of FUS in human embryonic kidney 293&#xa0;cells. In transgenic Drosophila that overexpress wt or P525L ALS-mutant human FUS in the retina or in neurons, we found coexpression of human CK1&#x3b4; or its Drosophila isologue Dco in the photoreceptor neurons significantly ameliorated the observed retinal degeneration, and neuronal coexpression of human CK1&#x3b4; extended fly life span. Taken together, our data suggest a novel regulatory mechanism of the assembly and toxicity of FUS through CK1&#x3b4;/CK1&#x3b5;-mediated phosphorylation, which could represent a potential therapeutic target in FUS proteinopathies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kishino</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsukawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Taisei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyazaki</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakabayashi</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Innovative Dementia Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nonaka</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kametani</LastName><ForeName>Fuyuki</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Tadafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan; Department of Innovative Dementia Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: tonchan@ncnp.go.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: iwatsubo@m.u-tokyo.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C113519">dco protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D048149">Casein Kinase 1 epsilon</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D048148">Casein Kinase Idelta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048149" MajorTopicYN="Y">Casein Kinase 1 epsilon</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048148" MajorTopicYN="Y">Casein Kinase Idelta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="Y">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012509" MajorTopicYN="Y">Sarcoma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">CK1&#x3b4;/&#x3b5;</Keyword><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">fused in sarcoma</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35753345</ArticleId><ArticleId IdType="pmc">PMC9293781</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2022.102191</ArticleId><ArticleId IdType="pii">S0021-9258(22)00633-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S., Neumann M., Rabe M., Meyer T., Ludolph A.C. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurol. 2010;75:815&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pubmed">20660363</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H., Josephs K.A., Rohrer J.D., Mackenzie I.R., Neumann M., Authier A., et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120:33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887939</ArticleId><ArticleId IdType="pubmed">20490813</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Roeber S., Kretzschmar H.A., Rademakers R., Baker M., Mackenzie I.R. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009;118:605&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864784</ArticleId><ArticleId IdType="pubmed">19669651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumann M., Cairns N.J., Munoz D.G., Isaacs A.M. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol. 2011;121:207&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">21052700</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz D.G., Neumann M., Kusaka H., Yokota O., Ishihara K., Terada S., et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009;118:617&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">19830439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann J.R., Seeley W.W., Huang E.J. RNA binding proteins and the pathogenesis of frontotemporal lobar degeneration. Annu. Rev. Pathol. 2019;14:469&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731550</ArticleId><ArticleId IdType="pubmed">30355151</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Cech T.R., Parker R.R. Biochemical properties and biological functions of FET proteins. Annu. Rev. Biochem. 2015;84:355&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188303</ArticleId><ArticleId IdType="pubmed">25494299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J.&#xa0;Neurochem. 2016;138:95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., et al. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyaschchenko A.K., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El Oussini H., Jambeau M., Sun Y., Mersmann S., et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G., Demestre M., Zuko A., Been M., Higelin J., Dieterl&#xe9; S., et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci. 2019;22:1793&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y., Washizu C., Kurosawa M., Yamada M., Miyazaki H., Akagi T., et al. FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2015;3:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408580</ArticleId><ArticleId IdType="pubmed">25907258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., et al. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Protter D.S.W., Rosen M.K., Parker R. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell. 2015;60:208&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke K.A., Janke A.M., Rhine C.L., Fawzi N.L. Residue-by-residue view of in&#xa0;vitro FUS granules that bind the C-terminal domain of RNA polymerase II. Mol. Cell. 2015;60:231&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., et al. A&#xa0;liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88:678&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray D.T., Kato M., Lin Y., Thurber K.R., Hung I., McKnight S.L., et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171:615&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes M.P., Sawaya M.R., Boyer D.R., Goldschmidt L., Rodriguez J., Cascio D., et al. Atomic structures of low-complexity protein segments reveal kinked &#x3b2; sheets that assemble networks. Science. 2018;359:698&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192703</ArticleId><ArticleId IdType="pubmed">29439243</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto T., Matsukawa K., Watanabe N., Kishino Y., Kunugi H., Ihara R., et al. Self-assembly of FUS through its low-complexity domain contributes to neurodegeneration. Hum. Mol. Genet. 2018;27:1353&#x2013;1365.</Citation><ArticleIdList><ArticleId IdType="pubmed">29425337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., Guo L., Caulfield T.R., Steyaert J., et al. Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep. 2018;24:529&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zbinden A., P&#xe9;rez-Berlanga M., De Rossi P., Polymenidou M. Phase separation and neurodegenerative diseases: a disturbance in the force. Dev. Cell. 2020;55:45&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">33049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner M., Toth R., Vandermoere F., Morrice N.A., Rouse J. Identification and characterization of FUS/TLS as a new target of ATM. Biochem. J. 2008;415:297&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">18620545</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Holler C.J., Taylor G., Hudson K.F., Watkins W., Gearing M., et al. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J.&#xa0;Neurosci. 2014;34:7802&#x2013;7813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., Burke K.A., Rhoads S.N., Zerze G.H., et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36:2951&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Sun F., Chen J., Chen L., Tobin-Miyaji Y., Xue S., et al. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J.&#xa0;Mol. Biol. 2020;432:467&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">31805282</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippschild U., Gocht A., Wolff S., Huber N., L&#xf6;hler J., St&#xf6;ter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell. Signal. 2005;17:675&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pubmed">15722192</ArticleId></ArticleIdList></Reference><Reference><Citation>Schittek B., Sinnberg T. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol. Cancer. 2014;13:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201705</ArticleId><ArticleId IdType="pubmed">25306547</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state. J.&#xa0;Neurochem. 1995;64:1420&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">7532213</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Yin H., Kuret J. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J.&#xa0;Biol. Chem. 2004;279:15938&#x2013;15945.</Citation><ArticleIdList><ArticleId IdType="pubmed">14761950</ArticleId></ArticleIdList></Reference><Reference><Citation>Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., et al. Constitutive phosphorylation of the Parkinson&#x2019;s disease associated &#x3b1;-synuclein. J.&#xa0;Biol. Chem. 2000;275:390&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">10617630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Nonaka T., Suzuki T., Arai T., Dohmae N., Akiyama H., et al. Identification of casein-kinase-1 phosphorylation sites on TDP-43. Biochem. Biophys. Res. Commun. 2009;382:405&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Suzuki G., Tanaka Y., Kametani F., Hirai S., Okado H., et al. Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1&#x3b4; triggers mislocalization and accumulation of TDP-43. J.&#xa0;Biol. Chem. 2016;291:5473&#x2013;5483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R. A&#xa0;new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Strutt H., Price M.A., Strutt D. Planar polarity is positively regulated by casein kinase I&#x3b5; in Drosophila. Curr. Biol. 2006;16:1329&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">16824921</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters J.M., McKay R.M., McKay J.P., Graff J.M. Casein kinase I transduces Wnt signals. Nature. 1999;401:345&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">10517632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Jia J., Wang B., Amanai K., Wharton K.A., Jr., Jiang J. Regulation of wingless signaling by the CKI family in Drosophila limb development. Dev. Biol. 2006;299:221&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855185</ArticleId><ArticleId IdType="pubmed">16987508</ArticleId></ArticleIdList></Reference><Reference><Citation>Muskus M.J., Preuss F., Fan J.Y., Bjes E.S., Price J.L. Drosophila DBT lacking protein kinase activity produces long-period and arrhythmic circadian behavioral and molecular rhythms. Mol. Cell Biol. 2007;27:8049&#x2013;8064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169192</ArticleId><ArticleId IdType="pubmed">17893330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal S. Genomic mapping and expression patterns of C380, OK6 and D42 enhancer trap lines in the larval nervous system of Drosophila. Gene Expr. Patterns. 2009;9:371&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602393</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippschild U., Kr&#xfc;ger M., Richter J., Xu P., Garc&#xed;a-Reyes B., Peifer C., et al. The CK1 family: contribution to cellular stress response and its role in carcinogenesis. Front. Oncol. 2014;4:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4032983</ArticleId><ArticleId IdType="pubmed">24904820</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin O., Bustos V.H., Cesaro L., Meggio F., Pagano M.A., Antonelli M., et al. A&#xa0;noncanonical sequence phosphorylated by casein kinase 1 in &#x3b2;-catenin may play a role in casein kinase 1 targeting of important signaling proteins. Proc. Natl. Acad. Sci. U. S. A. 2003;100:10193&#x2013;10200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC193538</ArticleId><ArticleId IdType="pubmed">12925738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Ghosh U., Thurber K.R., Kato M., Tycko R. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Nat. Commun. 2020;11:5735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665218</ArticleId><ArticleId IdType="pubmed">33184287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., McKnight S.L. The low-complexity domain of the FUS RNA binding protein self-assembles via the mutually exclusive use of two distinct cross-&#x3b2; cores. Proc. Natl. Acad. Sci. U. S. A. 2021;118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545455</ArticleId><ArticleId IdType="pubmed">34654750</ArticleId></ArticleIdList></Reference><Reference><Citation>Coady T.H., Manley J.L. ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev. 2015;29:1696&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561479</ArticleId><ArticleId IdType="pubmed">26251528</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen I., Rhoads S., Yee D., Wyne H., Gery K., Hannula I., et al. The prion-like domain of Fused in Sarcoma is phosphorylated by multiple kinases affecting liquid-and solid-phase transitions. Mol. Biol. Cell. 2020;31:2522&#x2013;2536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851872</ArticleId><ArticleId IdType="pubmed">32877292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks D.A., Cross L.L., Williamson R., Rattray M. Endoplasmic reticulum stress signaling induces casein kinase 1-dependent formation of cytosolic TDP-43 inclusions in motor neuron-like cells. Neurochem. Res. 2020;45:1354&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260270</ArticleId><ArticleId IdType="pubmed">31280399</ArticleId></ArticleIdList></Reference><Reference><Citation>Choksi D.K., Roy B., Chatterjee S., Yusuff T., Bakhoum M.F., Sengupta U., et al. TDP-43 phosphorylation by casein kinase I&#x3b5; promotes oligomerization and enhances toxicity in&#xa0;vivo. Hum. Mol. Genet. 2014;23:1025&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pubmed">24105464</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata F., Miura M. Enhancing S-adenosyl-methipnine catabolism extends Drosophila lifespan. Nat. Commun. 2015;6:8332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595730</ArticleId><ArticleId IdType="pubmed">26383889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R., Matsukawa K., Nagata Y., Kunugi H., Tsuji S., Chihara T., et al. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum. Mol. Genet. 2013;22:4474&#x2013;4484.</Citation><ArticleIdList><ArticleId IdType="pubmed">23804749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>